A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The aim of this study is to determine the safety and tolerability of elesclomol sodium at escalating doses (ultimately identifying the maximum tolerated dose). This study will also characterize the pharmacokinetics of elesclomol and evaluate its anti-tumor activity in advanced solid tumors that are metastatic and unresectable.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Males and females at least 18 years of age
Histologically- or cytologically- confirmed solid tumor (except melanoma) that is metastatic or unresectable
Advanced or metastatic cancer for which no standard therapy exists or that has progressed despite standard therapy
Acceptable organ and marrow function during the Screening Period as defined by the protocol.
Reliable venous access suitable for weekly study drug infusions
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Pregnant or breast-feeding women
Have had chemotherapy or radiotherapy within 4 weeks prior to entering the study
Primary brain tumors or active brain metastases
Treatment with chronic immunosuppressants
Significant cardiovascular disease, severe acute/chronic medical or psychiatric condition, or laboratory abnormality that may increase the risk associated with study participation or study drug administration